Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication

被引:76
作者
Ahn, Dae-Gyun [1 ]
Lee, Wooseong [1 ]
Choi, Jin-Kyu [1 ]
Kim, Seong-Jun [1 ]
Plant, Ewan P. [2 ]
Almazan, Fernando [3 ]
Taylor, Deborah R. [2 ]
Enjuanes, Luis [3 ]
Oh, Jong-Won [1 ]
机构
[1] Yonsei Univ, Dept Biotechnol & Translat Res, Ctr Prot Funct Control, Seoul 120749, South Korea
[2] US FDA, Lab Hepatitis & Related Emerging Agents, Div Emerging & Transfus Transmitted Dis, Off Blood Res & Review,Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA
[3] CSIC, Dept Cell & Mol Biol, Ctr Nacl Biotecnol, E-28049 Madrid, Spain
基金
新加坡国家研究基金会;
关键词
SARS-CoV; Frameshifting; Peptide nucleic acids; RNA replication; ACUTE RESPIRATORY SYNDROME; C VIRUS-RNA; ANTIVIRAL RESPONSES; GENE-EXPRESSION; VIRAL-RNA; PSEUDOKNOT; RECOGNITION; INHIBITION; SEQUENCE; GENOME;
D O I
10.1016/j.antiviral.2011.04.009
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The programmed -1 ribosomal frameshifting (-1 PRF) utilized by eukaryotic RNA viruses plays a crucial role for the controlled, limited synthesis of viral RNA replicase polyproteins required for genome replication. The viral RNA replicase polyproteins of severe acute respiratory syndrome coronavirus (SARS-CoV) are encoded by the two overlapping open reading frames 1a and 1b, which are connected by a -1 PRF signal. We evaluated the antiviral effects of antisense peptide nucleic acids (PNAs) targeting a highly conserved RNA sequence on the - PRF signal. The ribosomal frameshifting was inhibited by the PNA, which bound sequence-specifically a pseudoknot structure in the -1 PRF signal, in cell lines as assessed using a dual luciferase-based reporter plasmid containing the -1 PRF signal. Treatment of cells, which were transfected with a SARS-CoV-replicon expressing firefly luciferase, with the PNA fused to a cell-penetrating peptide (CPP) resulted in suppression of the replication of the SARS-CoV replicon, with a 50% inhibitory concentration of 4.4 mu M. There was no induction of type I interferon responses by PNA treatment, suggesting that the effect of PNA is not due to innate immune responses. Our results demonstrate that -1 PRF critical for SARS-CoV viral replication, can be inhibited by CPP-PNA, providing an effective antisense strategy for blocking -1 PRF signals. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 56 条
[1]
Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis [J].
Almazan, Fernando ;
DeDiego, Marta L. ;
Galan, Carmen ;
Escors, David ;
Alvarez, Enrique ;
Ortego, Javier ;
Sola, Isabel ;
Zuniga, Sonia ;
Alonso, Sara ;
Moreno, Jose L. ;
Nogales, Aitor ;
Capiscol, Carmen ;
Enjuanes, Luis .
JOURNAL OF VIROLOGY, 2006, 80 (21) :10900-10906
[2]
Programmed ribosomal frameshifting in decoding the SARS-CoV genome [J].
Baranov, PV ;
Henderson, CM ;
Anderson, CB ;
Gesteland, RF ;
Atkins, JF ;
Howard, MT .
VIROLOGY, 2005, 332 (02) :498-510
[3]
Recoding: translational bifurcations in gene expression [J].
Baranov, PV ;
Gesteland, RF ;
Atkins, JF .
GENE, 2002, 286 (02) :187-201
[4]
CHARACTERIZATION OF AN EFFICIENT CORONAVIRUS RIBOSOMAL FRAMESHIFTING SIGNAL - REQUIREMENT FOR AN RNA PSEUDOKNOT [J].
BRIERLEY, I ;
DIGARD, P ;
INGLIS, SC .
CELL, 1989, 57 (04) :537-547
[5]
Treatment of SARS with human interferons [J].
Cinatl, J ;
Morgenstern, B ;
Bauer, G ;
Chandra, P ;
Rabenau, H ;
Doerr, HW .
LANCET, 2003, 362 (9380) :293-294
[6]
Development of antiviral therapy for severe acute respiratory syndrome [J].
Cinatl, J ;
Michaelis, M ;
Hoever, G ;
Preiser, W ;
Doerr, HW .
ANTIVIRAL RESEARCH, 2005, 66 (2-3) :81-97
[7]
Inhibition of flavivirus infections by antisense oligorners specifically suppressing viral translation and RNA replication [J].
Deas, TS ;
Binduga-Gajewska, I ;
Tilgner, M ;
Ren, P ;
Stein, DA ;
Moulton, HM ;
Iversen, PL ;
Kauffman, EB ;
Kramer, LD ;
Shi, PY .
JOURNAL OF VIROLOGY, 2005, 79 (08) :4599-4609
[8]
ANTISENSE AND ANTIGENE PROPERTIES OF PEPTIDE NUCLEIC-ACIDS [J].
HANVEY, JC ;
PEFFER, NJ ;
BISI, JE ;
THOMSON, SA ;
CADILLA, R ;
JOSEY, JA ;
RICCA, DJ ;
HASSMAN, CF ;
BONHAM, MA ;
AU, KG ;
CARTER, SG ;
BRUCKENSTEIN, DA ;
BOYD, AL ;
NOBLE, SA ;
BABISS, LE .
SCIENCE, 1992, 258 (5087) :1481-1485
[9]
Interferon-β 1a and SARS coronavirus replication [J].
Hensley, LE ;
Fritz, EA ;
Jahrling, PB ;
Karp, CL ;
Huggins, JW ;
Geisbert, TW .
EMERGING INFECTIOUS DISEASES, 2004, 10 (02) :317-319
[10]
Hirschman SZ, 1996, J INVEST MED, V44, P347